impact:

LAG3 (CD223) as a cancer immunotherapy target

According to PR-model, LAG3 (CD223) as a cancer immunotherapy target is ranked 1,110,248th in multilingual Wikipedia, in particular this website is ranked 898,867th in English Wikipedia.

#Language
PR-model F-model AR-model
1,110,248th place
1,324,505th place
1,126,156th place
898,867th place
674,070th place
890,852nd place